生命科学资讯

10x Genomics Q4 Earnings Call Highlights - MarketBeat

Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics - Nasdaq

Thermo Fisher Scientific Inc. (TMO): Our Calculation of Intrinsic Value - The Acquirer's Multiple

Earnings roundup: Neurocrine slumps, Alnylam battles skeptics and Ascendis eyes a competitor

Thermo Fisher Issues $3.8 Billion Notes for Acquisition - TipRanks

10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 - Yahoo Finance

10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat

10x Genomics: Q4 Earnings Snapshot - WKYC

10x Genomics (NASDAQ: TXG) narrows 2025 losses and guides to modest 2026 growth - Stock Titan

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PR Newswire

Icon's stock drops 40% after disclosing internal accounting probe

Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance

Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback

AbbVie sues over selection of Botox for IRA negotiations

Pharma pushes back on FDA plans to ease prescription-OTC drug switches

Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance - AlphaStreet News

Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance - AlphaStreet News

Novo Nordisk to expand Irish factory for Wegovy pill

Financings for Feb. 12, 2026

In the clinic for Feb. 12, 2026